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High-energy collision-induced dissociation (CID) mass spectrometry provides a rapid and 
sensitive means for determining the primary sequence of peptides. The low-mass region 
(below mass 300) of a large number of tandem CID spectra of peptides has been analyzed. 
This mass region contains several types of informative fragment ions, including dipeptide 
ions, immonium ions, and other related ions. Useful low-mass ions are also present in 
negative-ion CID spectra. Immonium ions (general structure [H,N=CH-RI+, where R is the 
amino acid side chain) and related ions characteristic of specific amino acid residues give 
information as to the presence or absence of these residues in the peptide being analyzed. 
Tables of observed immonium and reiated ions for the 20 standard amino acids and for a 
number of modified amino acids are presented. A database consisting of 228 high-energy 
CID spectra of peptides has been established, and the frequency of occurrence of various ions 
indicative of specific ammo acid residues has been determined. Two model computer-aided 
schemes for analysis of the ammo-acid content of unknown peptides have been developed 
and tested against the database. (J Am Sot Mass Spectrom 1993, 4, 882-893) 
H igh-energy, tandem collision-induced dissocia- tion (CID) mass spectrometry provides a rapid and sensitive means of determining or verify- 
ing the amino acid sequences of peptides [l-6]. Mass 
spectrometric methods have several advantages over 
more conventional methods. First, they generally work 
as well for modified or unusual amino acid residues as 
for the 20 standard ones. Second, the peptide of inter- 
est need not be exhaustively purified; the method 
usually works as well on simple mixtures as on iso- 
lated peptides. Finally, acquisition of a tandem CID 
mass spectrum takes only a few minutes regardless of 
the composition of the peptide. At present, interpreta- 
tion of a spectrum of an unknown is less straightfor- 
ward, but programs for computer-aided interpretation 
are being developed 17-111. Interpretation of a peptide 
CID spectrum relies mainly on the sequence-specific 
ions present (a,, b,, c,, d,, x,, y,, z,, wn, and v, ions 
in the nomenclature originally proposed by Roepstorff 
and Fohlman [12] and elaborated by Biemann and 
co-workers [l, 7, 131). However, any additional infor- 
mation about the nature of the peptide that can be 
inferred, either from the CID spectrum or otherwise, 
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can enhance the performance of any interpretation 
strategy by reducing the number of candidate se- 
quences to be considered and by resolving ambigui- 
ties. 
The presence of immonium ions in a normal (2-sec- 
tori fast-atom bombardment (FAB) mass spectrum cor- 
responding to various amino acid residues present in a 
peptide was first reported by Barber et al. 114, 151. 
Renner and Spiteller [16] characterized the probable 
formation pathway for such ions, and Kausler et al. 
[17] systematically studied the immonium and their 
related fragment ions produced from amino acid 
residues in peptides by ion bombardment in a liquid 
matrix. 
Lippstreu-Fisher and Gross [IS] reported a few pep- 
tide-derived immonium ions in a 3-sector, tandem CID 
study. Biemann and co-workers 11, 2, 4, 5, 111 and 
Madden et al. 1191 have commented on the presence of 
such ions in 4-sector, tandem, high-energy CID spectra 
of peptides. A considerable amount of useful informa- 
tion can be obtained from these published spectra, but 
no systematic study has yet been undertaken to deter- 
mine the occurrence and characteristics of immonium 
and other low-mass ions with a view to eventually 
incorporating this information into a “second-genera- 
tion” computer-based scheme for interpretation of 
peptide CID spectra, using, for example, a pattern- 
based approach [B]. It is important to study all of the 
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ions present in CID spectra, because of their potential 
usefulness and also as a means of uncovering previ- 
ously uncharacterized fragmentation modes (see ref 20 
for example). In the present study, we have somewhat 
arbitrarily concentrated on the region below mass 300. 
We have studied a large number of high-energy CID 
mass spectra of peptides containing both normal and 
modified amino acids to better correlate the observed 
low-mass ions with peptide structure, in particular 
with the presence or absence of various residues in the 
peptide. As is shown below, a great deal of informs 
tion can be obtained from a careful examination of the 
ions of relatively low mass in such spectra. 
Experimental 
Mass Spectromety 
Tandem mass spectrometry experiments were carried 
out on a Kratos (Kratos Analytical Instruments, 
Manchester, U.K.) Concept IIHH 4-sector instrument of 
EBEB geometry [21], equipped with a liquid secondary 
ion mass spectromehy source [22,23] and a multichan- 
nel array detector [24] capable of acquiring data simul- 
taneously over a 4% mass window. Precursor ions 
were generated with an 18 keV Cs* primary beam. 
The acceleration voltage in the first mass spectrometer 
(MS-I) was 8 kV and the collision energy for CBJ was 4 
keV. The collision gas (He) was used at a pressure 
sufficient to suppress the precursor ion beam to about 
30% of its initial value. The instrument was controlled 
and data were acquired with a DS-90 data system. 
Spectra were acquired by stepping, in 4% decrements, 
from the precursor protonated peptide mass down to 
the lower mass limit. For simplicity, this process is 
referred to below as a scan. The lower limit was set to 
just below mass* 60 for most spectra, but a subset of 
earlier spectra were scanned to about mass 70. Rela- 
tively little useful information is contained below mass 
59, and a relatively long time is required to scan to 
lower masses on the system used for these measure- 
ments. (For example, the length of time required to 
scan from mass 60 to 30 is the same as that required to 
scan from 600 to 300.) Only peaks below an arbitrary 
cutoff of mass 300 were analyzed for this study. Cali- 
bration and data display were carried out with the aid 
of a Mach 3 data-processing system. Tandem CID 
spectra of more than 200 peptides were used in this 
study. Commercially available peptides were obtained 
from either Sigma (St. Louis, MO) or Bachem (Tar- 
rance, CA) and were used without further purification. 
(In a tandem CID mass spectrum, molecular ions from 
compounds of a different M, than the desired peptide 
are normally not transmitted through MS-I, although 
some artifacts have been noted [26].) Numerous other 
peptides were obtained as by-products of sequence 
analysis studies of various proteins of known or subse- 
quently verified sequences. In all of the latter cases, the 
peptides had undergone purification by high-perfor- 
mance liquid chromatography prior to tandem mass 
spectrometry. 
Data analysis. CID spectra were originally recorded as 
peak profiles. Automated data reduction of spectra 
was performed as follows, A peak detection routine, as 
previously described [8], was applied to each spec- 
trum. For convenience, abundances were taken simply 
as peak heights. A threshold was applied to the result- 
ing spectrum, which consisted of a list of peak abun- 
dances versus nominal masses, as follows. The number 
of peaks to be retained in the final list was equal to the 
nominal MH+ mass divided by 10 (90 peaks for a 
peptide of MH+ 9001, thus yielding a final average 
peak density in the spectrum of 1 peak per 10 Da. For 
all of the subsequent statistical work, except Scheme B, 
peak abundance data were not used except to establish 
the existence of a peak at a given mass. For Scheme 8, 
peaks were classified as strong, medium, or weak in 
the following way. All of the peaks below mass 200 
were renormalized such that the largest peak in this 
range was assigned an arbitrary abundance value of 
25. Those peaks with a renormalized abundance of 
between 5 and 25 were deemed strong, those between 
1 and 5 as medium, and the remainder were defined as 
weak. (This classification is crudely logarithmic.) Com- 
puter programs for analyzing spectra were written in 
C and run on a SPARCstation IPXTu computer (Sun 
Microsystems, Mountain View, CA). Additional prcr 
grams-were written to drive the prediction software 
and collate the results. Our database for this study was 
derived from a larger selection of CID spectra of pep 
tides of known sequence. Some spectra were excluded 
from the final database either to reduce the number of 
peptides with highly similar sequences or because of 
the quality of the spectra (due to either saturation of 
dau&ter ions or low signal intensity). However, some 
spectra of lesser quality were included to increase the 
diversity of our sample with respect to overreprc- 
sented and underrepresented amino acids. 
Interpretive programs were designed to suggest 
amino acid residues that were likely absent (“ex- 
eluded”) or present (“required”) in the peptide from 
which the sp&rum under examination was produced. 
In cases where no prediction could be made, the residue 
was “allowed.” Predictions were restricted to geneti- 
tally encoded amino acids. Predictions for Gly and Ala 
were not attempted, as we did not scan low enough to 
detect their immonium ions. No attempt was made to 
distinguish between the isomeric pair, ieu and Ile, and 
the isobaric pair, Lys and Gln. 
‘We refer to fragment ion mass rather than mass-to-charge ratio in 
this article because the fragment ions are known to be singly charged. 
A multiply charged fragment ion formed from a singly charged 
precursor in the collision cell of a Csector, tandem machine under 
normal operating conditions (floated collision cell) would not appear 
at all in‘ the f&gment-ion spectrum. Such an ion would not be 
simultaneously transmitted through E2 and 82 of MS-II during the 
linked ~carn of these two fields [251. 
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Results and Discussion 
The identifiable peaks observed in the low mass region 
of the peptide CID spectra we examined can conve- 
niently be divided into three classes. The first class 
consists of normal sequence ion peaks that happen to 
fall in this mass range. These were easily identified 
and were not studied further. Second are dipeptide-ion 
peaks arising from internal acyl ions or immonium 
ions (designated by the dipeptide single-letter code or 
the dipeptide single-letter code - 28, respectively ) [4, 
131. The internal acyl ions have masses equal to the 
sum of the residue masses plus one and correspond to 
y,,,b, cleavages, while the immonium ion mass (y,a, 
cleavage) is 28 Da less than that of the respective acyl 
ion. 
In our data, dipeptide ions are often abundant when 
one of the residues gives rise to a strong immonium 
ion of its own and/or when cleavage at one of the 
residues is favored, such as at the N-terminal side of 
Pro or, to a lesser extent, Gly. Peaks corresponding to 
losses of water (if the dipeptide contains Thr, Ser, Asp 
or Glu) or ammonia (from Arg, Lys, Gln, or Asn) from 
dipeptide ions are sometimes also observed. These are 
particularly intense when the dipeptide is at the N- 
terminus (i.e., az - 17 or 18 and b, - 17 or 18 ions). 
On the other hand, peaks corresponding to immonium 
or acyl dipeptidc ions from the two C-terminal residues 
of a peptide are only rarely observed. 
Dipeptide ion peaks can aid in interpretation of CID 
spectra. It is frequently the case that two more-or-less 
equally satisfactory interpretations of a spectrum of an 
unknown peptide differ by a dipeptide inversion, for 
example, VSWAMFPNGK or SVWAMFPNGK. The 
presence of a strong dipeptide signal for SW (mass 
274) and not for VW (286) was an important clue to the 
correct sequence in this case [27]. 
The third class of peaks found in the low-mass 
region is due to immonium and related ions. Immo- 
nium ions have the general structure ]H2N=CH-RI+, 
where R is the ammo acid side chain; their mass is 27 
Da less than the residue mass [13]. The related ions are 
those observed in the CID spectrum when certain 
residues are present in a peptide. Immonium ions for 
most of the standard ammo acid residues and for 
many modified residues are prominent in high-energy 
CID mass spectra and offer the obvious possibility of 
providing useful information about the amino acid 
composition of an unknown peptide. Compositional 
constraints thus determined can be used to assist sub- 
sequent sequence determination. 
In Table 1 are listed the observed immonium and 
related ion masses. Table 1 is a qualitative summary of 
manual examination of several hundred peptide CID 
spectra. Much of the information contained in Table 1 
is in accord with previous work [II]. Figure 1 shows 
the low mass region of the tandem CID spectrum of 
the peptide Ac-GlyyIle-Gln-Glu-Leu-Tyr-Gly- 
Ala-Ser-NH,. The peaks in this spectrum are labeled 
according to the conventional nomenclature [13]. The 
spectrum contains abundant immonium ion peaks for 
the residues Ile/Leu (mass 861, Gln (84, lOl), and Tyr 
Table 1. Immonium and related ions characteristic of the 20 standard amino acids 
Amino acid lmmonium Related ion Comments 
residue ion mass masses 
Ala 44 
Arg 129 112,100,67, 129, 73 usually weak 
73, 70. 59 
ASP 88 Weak or absent if C-terminal 
ASll 87 70 87 often weak, 70 weak 
CYS 76 Usually weak 
Glv 30 
Girl 101 84, 129 129 weak 
GIU 102 Often weak if C-terminal 
His 110 62, 121, 123, 110 very strong; 82, 121, 
138,166 123, 138 weak or absent 
Ile /Leu 86 72 86 strong, 72 weak very 
LYS 101 129. 1 12, 84, 101 can be weak, 70 weak or 
70 absent 
Met 104 61 104 often weak or absent 
Phe 120 91 120 strong, 91 weak 
Pro 70 Strong 
Ser 60 
Thr 74 
Trp 159 171,170.130, St rang except 117 
117 
Tvr 136 107.91 136 strong; 107. 91 weak 
Val 72 Fairly strong 
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Figure 1. Tandem CID mass spechum of the peptide AC-Gly-lie-GLn-Glu-Leu-TyrC;ly-Ala-Ser-NR, 
Singte amino acid immonium and related ion peaks are marked with their corresponding single 
letter code. Dipeptide acyl and immonium ion peaks are also indicated bz text) as BR the normal 
sequence ions. 
(136); weaker immonium ion peaks can be seen for Ser 
(60), Glu (102), and AC-Gly (72). (Note that the peak at 
mass 72 has the same nominal mass as the valine 
immonium ion and therefore would be masked if 
valine were present.) A number of internal dipeptide 
ions, and one tripeptide ion, are also present. 
The usefulness for interpretation purposes of the 
immonium and related ions varies a great deal for 
different amino acid residues. For example, the cluster 
of ions produced by Arg is usually easily recognized, 
as are the characteristic ions from His, Leu/Ile, Phe, 
Tyr, and Trp. The apparent stability of these ions can 
be rationalized on the grounds of favorable resonance 
effects or inductive effects from alkyl side-chain 
groups. The immonium ions of a few residues, such as 
Asp and Glu, are sometimes weak or absent, perhaps 
because the electron-withdrawing carboxyl group 
destabilizes the positive ion. Madden et al. [19] have 
noted that immonium ions from N-terminal residues 
(a, ions) tend to be enhanced in abundance relative to 
the immonium ion from the same residue located in 
the C-terminal position. They also suggest that some 
competition for charge may occur among immonium 
ions. Our data show quite clearly that the abundance 
of immonium ions from residues in the C-terminal 
position is markedly less than for residues in any other 
position in the peptide. Indeed, the lack of immonium 
ions for some C-terminal residues is a major obstacle 
to attempts to automate interpretation. 
In some cases, interferences occur. Prolime produces 
a strong ion at mass 70 for which a stable cyclic 
structure can be drawn and which is an excellent 
indication of the presence of this residue; however, 
Arg also gives rise to a strong ion at this same mass, so 
that the presence of Pro cannot be confirmed in the 
presence of Arg. Similarly, the mass 87 ion of Asn is 
masked if Arg is present. In our experience, it is not 
possible to distinguish between the isobaric pair of Gln 
and Lys on the basis of their immonium ions: both can 
produce peaks at mass 84 and 101, although the mass 
101 peak due to Lys is sometimes quite weak. A 
distinction between Lys and Gln can sometimes be 
made based on clues obtained from sequence ions in 
the spectrum. However, we believe that, at this stage, 
these clues are too subtle to attempt the distinction via 
software. Acetylation of the e-amino group of Lys 
followed by molecular weight measurement [28] or, if 
necessary, a second tandem CID spectrum (eacetylly- 
sine has a distinctive immonium ion, see below), can 
provide a definitive answer. 
The “related ions” listed in Table 1 usually can be 
rationalized easily. Their masses generally correspond 
to neutral losses or other logical modifications of the 
standard irnrnonium ions. For example, the ion pro- 
duced by Met at mass 61 corresponds to CH&CHl. 
Arginine is the source of a large number of low-mass 
fragment ions, presumably because of its ability to 
stabilize positive charge at a number of different sites. 
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The actual structures of these and other ions referred 
to in this paper are, in general, unknown. 
A variety of peptides containing nonstandard or 
modified amino acid residues has also been examined. 
One of the most important pieces of information avail- 
able from the low-mass ions in a CID spectrum is 
indication or confirmation of the presence of a modi- 
fied or nonstandard amino acid residue. In fact, the 
ability to detect and identify such residues is a major 
advantage of mass spectrometric methods. Table 2 is a 
list of a number of modified residues and the masses 
of the associated characteristic positive-ion, high-en- 
ergy CID peaks observed. The immonium ions gener- 
ated from modified residues nearly always produce 
peaks at the expected mass, namely 27 Da less than the 
modified residue mass. In the case of N-terminal mod- 
ifications, the immonium ion is of course identical to 
the a, ion. Acetylated N-terminal residues usually also 
give rise to a peak at the “normal” immonium ion 
mass (42 Da less). Residues at the C-terminus of a 
peptide that have a modified carboxyl group (esters, 
for example) show only the normal immonium ion 
because the carboxyl group is not present in any case 
in the immonium ion. Dihexylated [291 C-terminal 
residues (Asp, Glu), usually show an immonium ion 
containing one hexyl group as well as the normal 
immonium ion, which is often weak. Side-chain hexyl 
esters of aspartate, glutamate, and carboxymethylcys- 
teine in non-C-terminal positions also give immonium 
ion peaks both with and without the modifying groups. 
As an example of a peptide containing modi- 
fied residues, Figure 2 shows the low mass region of 
the tandem CID spectrum of the peptide 
pyroGlu-Tyr-Gly-Phe-Cys*-Lys. The cysteine 
residue has been modified with 4-vinylpyridine 1301 to 
convert it to S-P-Cethylpyridyl cysteine. This modified 
residue gives a very distinctive group of characteristic 
peaks, dominated by ~SS 106 (CH,=CH-C~H~N+) 
(see Table 2). The expected peak at mass 84 from 
pyroGlu is masked in this case by the Lys peak at the 
same mass. 
Negative-Ion Peaks 
The phosphorylated and sulfated amino acids are the 
only amino acids documented [31, 321 to give strong 
characteristic low-mass peaks in negative-ion, high+n- 
ergy CID spectra of peptides. However, no systematic 
study has been conducted to determine the presence or 
absence of characteristic low-mass ions for individual 
amino acids in the negative-ion mode. Phosphoserine, 
phosphotyrosine, and sulfated tyrosine all give abun- 
dant peaks corresponding to deprotonated immonium 
ions (NH=CH-R-j, where the negative charge is pre- 
sumably located on the side-chain phosphate or sulfate 
group. This gives rise to a peak 2 Da lower than the 
corresponding immonium-ion peak in the positive-ion 
mode (i.e., mass 214 for phosphotyrosine and sulfoty- 
rosine and mass 138 for phosphoserine). The latter also 
gives abundant peaks at mass 79 and 97 [32]. Phospho- 
Table 2. Immonium and other ions from nonstandard amino acid residues 
Amino acid residue lmmonium Related ion Comments 
ion mass masses 
Acetylglutamate 144 102 N-terminal 
eAcetyllysine 143 126 
Acetylproline 112 N-terminal 
Acetyltyrosine 178 136 N-terminal 
Acetylphenylalanine 162 120 N-terminal 
Aminoethylcysteine 120 
3-Carboethoxyhistidine 182 110 
Carboxymethylcysteine 134 
S-/3-4-Ethylpyridyl cysteine 181 138.106,93 106 strong, 191, 138, 93 
can be weak 
/3-Hexyl aspartate 172 88 88 weak 
Hexyl carboxymethylcysteine 218 134 
YHexyl glutamate 166 102 102 weak 
Hydroxyproline 86 
3.Hydroxytyrosine 152 
4-Methylphenylalanine 134 
Norleucine 86 
Phosphoserine 140 
Phosphotyrosine 216 Moderate to strong 
Pyroglutamic acid 84 N-terminal 
Sulfotyrosine 216 
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Figure 2 Tandem CID spectrum of the peptide pyroGlu-TyrCly-Phe-Cys*-Lys. Cys’ is Speethyl- 
pyridyl cyst&w. 
tyrosine and sulfotyrosine give rise to a further series 
of fragment peaks, shown in Table 3. 
The occurrence of characteristic or “indicator” peaks 
that are associated with the presence of a correspond- 
ing residue in a peptide can be quantified. Due to the 
limited amount of data available for modified residues 
and in negative mode, the quantitative work has been 
limited to the positive-ion CID spectra of peptides 
containing the 20 genetically encoded amino acids. Of 
these, we have grouped the isomeric pair, Leu and Ile, 
and the isobaric pair, Gin and Lys, together. We have 
further neglected Gly and Ala because most spectra 
were not scanned to low enough mass to detect their 
immonium ions. Our study sought to determine how 
strongly the presence or absence of an indicator peak 
correlates with the presence or absence of the corre- 
sponding amino acid. The closely related question, that 
of whether the presence of an amino acid in a peptide 
will give rise to the indicator peak in its CID spectrum, 
is also addressed. 
These questions are best answered using a com- 
puter-accessible database of CID spectra, which we 
have generated from our collected data. Initially, peaks 
were classified as present or absent based on whether 
their abundances exceeded the calculated threshold 
value (see Experimental section). It should be noted 
that peaks that fall below the threshold for a given 
spectrum may still be useful to a skilled human inter- 
preter. Similarly, peaks that exceed the threshold may 
be discounted based on experience. This last observa- 
Table 3. Characteristic low mass ions found in high-energy negative ion tandem 
CID mass spectra of pepttdes containing phosphotyrosine and sulfotyrosine 
Residue Mass of characteristic 
peak 
Suggested structure 
Phosphatyrosine 
Sulfotyrosine 
214 NH=CH-CH,-C,H,OPO,H- 
199 CH,=CH-C,Hz,OPO,H- 
186 XH,C,H,OPO,Hm 
97 H,PO; 
79 PO, 
214 NH=CH-CH,-C,H,OSO; 
199 CH,=CH-CsH40S0; 
186 CH&,H,OSO; 
96 30; 
80 .so, 
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tion is particularly true for small peptides (less than 
six residues). 
The results of our analysis of the 228 spectra in the 
database are shown in Table 4, which gives the fre- 
quency of occurrence (in %) of indicator peaks in the 
CID spectra of peptides containing each amino-acid 
residue. For the purposes of the following discussion, 
it is convenient to define four logical categories of 
spectra. The designation T + indicates a spectrum that 
contained both an amino acid and its indicator peak, 
and T- indicates spectra containing the amino acid 
but not a detectable indicator peak (above threshold). 
Similarly, F + and F - describe spectra of peptides not 
containing the residue in question but which do and 
do not, respectively, contain the corresponding indica- 
tor peak. 
In most cases, a total of N = 228 spectra were exam- 
ined, but because some spectra were not scanned low 
enough, N varies for ions of mass 59, 60, and 61, as 
indicated in Table 4. All indicator peaks listed show 
some positive correlation with their respective amino- 
acid residue. As an example, consider the mass 74 
peak for Thr. 82% (71/87) of the spectra with a peak at 
mass 74 were from peptides containing Thr. Further- 
more, only 6% of those spectra without a peak at mass 
74 were from peptides that contained a Thr residue. 
Thus, if our collection of spectra is representative, one 
could say that if there is a peak at mass 74, the 
probability that the peptide contains threonine is 82%, 
and similarly, if there is no peak at this mass, the 
likelihood that threonine is present is 6%. The situa- 
tion is somewhat different for mass 70 as an indicator 
for Pro. In this case, the presence of a peak at this mass 
only correlates with the presence of Pro in 45% of the 
cases. This is mainly due to the mass 70 ion that is also 
associated with Arg. However, if there is no peak at 
mass 70, then one can be 100% certain (within the 
limits of the database) that Pro is absent. Negative 
information of this type is just as valuable as positive 
information in the context of assisting in the interpreta- 
tion of the CID spectrum of an unknown peptide. 
A different perspective is illustrated in Figure 3. 
This histogram shows the fraction of the spectra con- 
taining each individual indicator peak that can be 
classified into the four logical categories, T + , T - , F + 
and F - . The histogram shows the first three cases; the 
fourth, F - , is given by the difference between the sum 
of the first three and unity. 
It is evident from Tables l-3 and Figure 3 that a 
good deal of information about the amino-acid compo- 
sition of an unknown peptide can be obtained from a 
thoughtful examination of the low-mass portion of the 
CID spectrum, but that this approach is not without 
pitfalls. We therefore used the database to test various 
possible schemes for computer-aided interpretation of 
amino acid composition. This “amino-acid-composi- 
tion module” was designed ultimately to be used in 
combination with the computer-aided spectral inter- 
pretation program developed in our laboratory [81. As 
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Table 4. Frequency of occurrence of indicator peaks and 
amino acid residues in the data base” 
Residue N n mess m T+/m T-/(N-m) 
(Da) (%J (%I 
CYS 
Asp 
GIU 
Phe 
His 
Lys/Gln 
Ile /Leu 
Met 
Asn 
Pro 
Aw 
Ser 
Thr 
Val 
Trp 
Tvr 
228 9 
228 84 
228 98 
228 79 
228 79 
228 55 
228 55 
228 55 
228 55 
228 55 
228 55 
228 134 
228 134 
228 134 
228 134 
228 134 
228 191 
228 191 
162 9 
228 16 
228 59 
228 89 
94 39 
228 85 
228 85 
228 85 
228 85 
228 85 
228 85 
162 63 
228 79 
228 119 
228 12 
228 12 
228 12 
228 12 
228 12 
228 55 
228 55 
228 55 
76 5 
88 104 
102 92 
91 52 
120 86 
82 64 
110 89 
121 50 
123 33 
138 60 
166 70 
70 196 
84 189 
101 98 
112 123 
129 141 
72 157 
86 200 
61 5 
104 22 
87 104 
70 196 
59 27 
70 196 
73 66 
87 137 
100 112 
112 123 
129 141 
60 64 
74 87 
72 157 
117 23 
130 125 
159 91 
170 51 
171 98 
91 52 
117 34 
136 73 
20 
62 
a7 
71 
90 
52 
61 
76 
91 
62 
69 
56 
68 
80 
54 
80 
80 
94 
100 
64 
31 
45 
89 
43 
43 
60 
71 
67 
30 
61 
82 
73 
30 
10 
13 
24 
24 
50 
85 
70 
4 
15 
13 
24 
1 
13 
1 
10 
13 
11 
4 
75 
15 
43 
65 
24 
92 
14 
3 
1 
22 
0 
22 
3 
3 
3 
4 
2 
48 
24 
6 
6 
2 
0 
0 
0 
8 
16 
13 
3 
“N = total number of spectra examined, n = number of spectra 
containing the given amino acid residue, and m = number of spec- 
tra containing a peak at the Indicator mass T+/m IS the fraction Of 
the spectra containing the peak that also contain the correspond- 
ing amino acid. and T - /(N-m) is the fraction of the spectra that 
did not contain the given indicator peak but came from peptides 
that did contain that amino acid residue. 
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Figure 3. Histogram showing the fraction of spectra in the database that contain certain indicator 
peaks and the corresponding residues. 
mentioned, the database did not contain sufficient 
spectra to include modified or nonstandard ammo acid 
residues; however, it is perfectly possible to add addi- 
tional rules in the future. 
The logical rules for a rather simple scheme (Scheme 
A) based mainly on the presence or absence of various 
immonium ions are shown in Table 5. In this scheme, 
if the CID spectrum contains a peak (above threshold) 
at mass 102, for example, all sequences proposed by 
the interpretation module of the program would be 
constrained to include at least one Glu residue. Simi- 
larly, if this peak is absent, any proposed sequences 
containing Glu would be excluded. In a slightly more 
complicated case, the presence of three or more peaks 
at masses characteristic of His would be sufficient to 
require the presence of this residue in all candidate 
sequences, while the presence of fewer than two would 
exclude it. If exactly two of these indicator peaks were 
present, no firm conclusion could be made, so that all 
candidate sequences, whether or not they contained 
His, would be allowed. 
The logic for a more sophisticated scheme (Scheme 
Bl for determining amino-acid composition is shown in 
Table 6. In addition to taking account of possible 
interferences between indicator masses from different 
residues, this scheme also uses (crude) ion abun- 
Table 5. Simple set of logical rules (Scheme A1 for deducing the presence or absence of 
amino acid residues based on the number of indicator peaks present in the CID spectrum 
AA Masses Require if 2 Exclude if 5 
Simple* 
His 
Leu /lle 
Lys/Gln 
Met 
*r9 
TOP 
Tvr 
immonium ion mass 
82, lt0, 121,123, 136, 166 
72,86 
70.84,101,112,129 
61, 104 
59. 70. 87. 100. 112, 129 
117.130.159,170,171 
91, 107, 136 
-Includes Asp, Cys. Glu. Phe. Asn. Pro. Ser. Thr and Val. 
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Table 6. More sophisticated logic scheme (Scheme 8) for determining the amino acid 
composition of a peptide from its CID spectrum* 
AA Test Prediction 
Simple* lmmonium ion mass strong or medium + 
lmmonium eon mass absent _ 
All orher cases 0 
ASfl 87 strong or medium and Arg predicted absent + 
87 absent _ 
All other cases 0 
Pro 70 strong or medium and 87, 100, and 112 all absent + 
70 absent _ 
All other cases 0 
SW 60 strong or medium and Arg predicted absent + 
60 absent - 
All other cases 0 
His 110 strong + 
or 110 medium and at least 2 of X2, 121, 123, 136, and 166 present + 
110 absent _ 
All other cases 0 
Arg 100 strong or medium, 87 and at least two of 59, 70. 112. or 129 present + 
100 strong or medium, 87 and less than two of 59, 70, 112. or 129 present 0 
or 87 or 100 present and at least one of 59, 70, 112, or 129 present 0 
All other cases _ 
Lys /Gin 84 and 101 strong and weak (either order) or both medium + 
or 84, 101, 112, and 129 all present + 
84 and 101 both absent _ 
All other cases 0 
Trp 130 and 159 strong and weak (either order) or both medium and 171 present+ 
130 and 159 strong and weak (either order) or both medium and 171 absent 0 
or 130 and 159 both present 0 
or 171 present and either 130 or 159 present 0 
All other cases 
Tvr 136 strong or moderate and at least one of 91 or 107 present + 
136 absent - 
All other cases 0 
aThe prediction “+” means that all candidate sequences must contain this residue, *‘p” means that 
n?ne may contain it, and “0” means that the sequences may or may not contain it. 
The designation “simple” refers to residues for which only one mdicator peak is used. namely their 
immonium ion, These are Cys, Asp, Glu. Phe (91 not used), Ile/Leu (72 not used), Met (61 not used). 
Thr. and Val. 
dances, rather than simply determining if a peak is 
above threshold. In this scheme, peaks are defined as 
being strong, medium, or weak (see Experimental sec- 
tion). To be “present,” a peak simply has to exceed the 
lowest threshold. 
Figure 4 illustrates the results obtained when these 
two logic schemes were applied to the spectra in our 
database. Figure 4a displays the accuracy of predic- 
tions of the presence of each residue (required). Each 
bar represents the fraction of all spectra of peptides 
containing the given residue that were predicted to 
contain that residue. The shaded bars are for Scheme 
A, while the black bars are for Scheme B. Figure 4b 
shows the fraction of spectra of peptides not contain- 
ing each residue, for which the logical rules gave a 
result of excluded. Figure 4c and d show the fraction 
of incorrect predictions, false negatives and false posi- 
tives, respectively. 
Although Scheme A gives a greater fraction of cor- 
rect predictions than Scheme 8, it also yields a greater 
fraction of incorrect predictions. This is a consequence 
of more stringent criteria for the classifications of re- 
quired and excluded in Scheme B. The result is that a 
greater fraction of the overall predictions from Scheme 
B fall into the allowed category, and thus do not 
appear explicitly in Figure 4. The data shown in Figure 
4 for Cys make it clear that an accurate prediction of 
the presence or absence of this residue is not possible. 
Similarly, it is not possible to accurately exclude Asp, 
Ser, or Glu, although their presence is predictable with 
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Scheme A Scheme 6 Scheme B’ 
Figure 5. Overall results for three prediction schemes. (a) Scheme A, (b) Scheme 8, (c) Scheme 8’ 
(same as Scheme B, buC Asp, Ser and Glu are never excluded, and no predictions are attempted for 
Cys). 
be added. Scheme B is currently used in our laboratory 
as shown (with a few omissions, as discussed above), 
but future improvements are likely as our experience 
continues to increase. 
Conclusions 
The low-mass region of high-energy, tandem CID 
spectra of peptides contains a wealth of information, 
mainly about the amino-acid composition of the pep- 
tides. These data definitively show the presence or 
absence of many amino acid residues, although the 
complete amino acid composition cannot be deduced 
in most cases. The information obtained is extremely 
valuable in generating or narrowing the choice of pos- 
sible candidate sequences for the determination of the 
sequence of an unknown, either manually or by using 
a computer-aided scheme. Rules can be developed to 
provide computer-assisted evaluation of the amino- 
acid content of an unknown peptide from its CID 
spectrum. This process can be integrated into an over- 
all computer-aided spectrum-interpretation scheme or 
simply used as an aid in manual interpretation. In 
either case, unknown peptide sequence determination 
is enhanced. 
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